Kevin Pojasek

ceo / venture partner / company builder / kendall sq expat

[Kevin Pojasek @drkpoj]

Are you a leader in cell therapy research looking for a new adventure? Please join us for the next phase of our journey! @Enara_Bio

[Enara Bio @Enara_Bio]

We are growing our team at #EnaraBio! We are excited to share the newly created role of Vice President of Cell Therapy Research. Please follow https://t.co/i5LLBSv9ad to learn more and apply #Careers

[Enara Bio @Enara_Bio]

We are rebranding as Enara Bio to reflect a broader emphasis on the discovery and development of novel #TCR based cancer #immunotherapies
https://t.co/B92YWWGa3d

[Kevin Pojasek @drkpoj]

The beginning ends
Ervaxx lives in Enara
We light the voyage https://t.co/SDaud3CRGE

[Kevin Pojasek @drkpoj]

@musical_lou @BigAllster @ucl Amazing achievement! Congrats to all the Doctors Naylor!!

[Enara Bio @Enara_Bio]

Thrilled today to announce our collaboration with @cardiffuni to develop novel #Tcell and #TCR immunotheraies targeting #DarkAntigens. We will also build on exciting new research in @NatImmunol identifying #MR1 as a target for novel #immunotherapy. https://t.co/vtQL3d7Qo8

[Enara Bio @Enara_Bio]

Come work with us!

We are looking for a Scientist/Senior Scientist to join our growing immunology team and help develop #darkantigens for #cancer #immunotherapy. See our website for more info and to apply: https://t.co/75N3BG799l

[Vanessa King @VanessaE_King]

Congrats, Arkuda team! Looking forward to hearing news of future progress.

[Enara Bio @Enara_Bio]

We're excited to be presenting our first data at the @sitcancer annual meeting on Nov 9: ‘Discovery of immunogenic ERV-derived antigens as targets for melanoma immunotherapy.’ https://t.co/2b2jrRKaFQ #DarkAntigens #cancervaccines #immunotherapy #melanoma

[Kevin Pojasek @drkpoj]

Thrilled to formally unveil our Dark Antigen discovery efforts @ErvaxxLtd today! Fascinating area of emerging biology - non-canonical ORFs generating shared tumor-specific T-cell antigens.

[Enara Bio @Enara_Bio]

Read about us in this Emerging Company Profile on @BioCentury

[Kevin Pojasek @drkpoj]

Look who we ran into in London! Go Sox! #LondonSeries

[Kevin Pojasek @drkpoj]

Congrats, gents! Impressive next step for team Atlas.

[Atlas Venture @atlasventure]

We are excited to announce the first Atlas Venture Opportunity Fund, building upon our venture creation model with growth investments in high-potential Atlas portfolio companies. Learn more here: https://t.co/slaYZoPiko

[Kevin Pojasek @drkpoj]

And a great CEO! What’s not to love!? Congrats, Jeff.

[Jeff Jonker @Jeff_Jonker]

Thrilled to be part of the @ambysmedicines team! Terrific colleagues, bold science, amazing founders, top investors, great partnership, three platforms (traditional, gene and cell therapy approaches) and planning to make liver transplants obsolete. This is going to be fun!

[Immunocore @Immunocore]

The Immunocore Autoimmune team representing at @KeystoneSymp conference - Frontiers in Islet Biology & Diabetes. Their first poster at an international conference - great job guys!

[Immunocore @Immunocore]

Immunocore is so proud of our employee Alex Powlesland -the UK's most prolific inventor - Read about his achievements in an @Oxfordtimes article here https://t.co/qLZlkqmt8w

[Bill Gates @BillGates]

I’m excited about the possibilities that exist at the intersection of global health and the private sector. I spoke about how companies can harness these opportunities earlier today. https://t.co/wd6Q6JBma4

[Kevin Pojasek @drkpoj]

@BillGates highlighting the partnership with @Immunocore to deploy our TCR-based I/O technology to treat infectious diseases. #JPM18

[Kevin Pojasek @drkpoj]

@biologypartners @AF_biotech Ran the Ph 2 study with PPF while at Solace. Not sure we properly tested the glial cell-pain hypothesis due to the molecule's non-specific pharmacology and subpar CNS penetration. Definitely worth another crack at this biology with a better target/drug.

[Mark Tebbe @Mark_Tebbe]

Quartet was a great team all the way around - internal team, investors, founders, SAB. But science happens. At it again already though . . . https://t.co/c2ivxMx1Ci

[Vanessa King @VanessaE_King]

Congrats #DDF - what a great partner in tackling dementia! Patients and their families are waiting with baited breath! https://t.co/aFLgtFh4Jm

[Kevin Pojasek @drkpoj]

Is that the inimitable @MikeDybbs front and center at our SITC poster!? https://t.co/Yhlp0BcYxP

[Immunocore @Immunocore]

Immunocore presents promising overall survival data with #IMCgp100 in #Uveal #Melanoma. Thanks to Dr. Omid Hamid @OmidHamidMD for presenting at SITC. #SITC2017